Metabolism of pyridoxine in mild metabolic hyperoxaluria and primary hyperoxaluria (type 1).
Plasma pyridoxine metabolites in plasma and 4-pyridoxic acid excretions in urine were measured in normal subjects, in 7 patients with type-1 hyperoxaluria and in 8 patients with mild metabolic hyperoxaluria, while receiving various doses of pyridoxine. Compliance with ingestion of pyridoxine was verified by measuring urinary 4-pyridoxic acid. In the normal subjects the maximum level of pyridoxal phosphate was obtained after only 10 mg/day of pyridoxine. The patients were divided into nonresponders, good responders and poor responders to pyridoxine according to the fall in urinary oxalate and glycollate excretions. In patients taking pyridoxine, the plasma pyridoxal phosphate levels were as for normal subjects in primary hyperoxaluria, lower than for normal subjects in mild metabolic hyperoxaluria (p less than 0.01), and in the latter group lower in partial responders than in good responders (p = 0.04). Hence in mild metabolic hyperoxaluria there may be difficulty in converting pyridoxine to pyridoxal phosphate.
Edwards
P
P
St Peter's Hospitals and Institute of Urology, London, UK.
Rose
G A
GA
D002851:Chromatography, High Pressure Liquid; D006801:Humans; D006959:Hyperoxaluria / Q000188:drug therapy / Q000378:metabolism*; D006960:Hyperoxaluria, Primary / Q000188:drug therapy / Q000378:metabolism*; D011735:Pyridoxic Acid / Q000652:urine; D011736:Pyridoxine / Q000493:pharmacokinetics* / Q000627:therapeutic use
D011735:Pyridoxic Acid; D011736:Pyridoxine